Cargando…
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections
BACKGROUND: Immune checkpoint inhibitors (ICI) substantially improve outcome for patients with cancer. However, the majority of patients develops immune-related adverse events (irAEs), which can be persistent and significantly reduce quality of life. Neurological irAEs occur in 1–5% of patients and...
Autores principales: | Schmitt, C., Hoefsmit, E. P., Fangmeier, T., Kramer, N., Kabakci, C., Vera González, J., Versluis, J. M., Compter, A., Harrer, T., Mijočević, H., Schubert, S., Hundsberger, T., Menzies, A. M., Scolyer, R. A., Long, G. V., French, L. E., Blank, C. U., Heinzerling, L. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576679/ https://www.ncbi.nlm.nih.gov/pubmed/37606856 http://dx.doi.org/10.1007/s00262-023-03498-0 |
Ejemplares similares
-
Differences in neurotropism and neurotoxicity among retrograde viral tracers
por: Sun, Leqiang, et al.
Publicado: (2019) -
Preliminary seroprevalence study of neurotropic virus antibodies in Nodding syndrome
por: Angues, Raquel Valdes, et al.
Publicado: (2022) -
Neurotropism of Salvarsan
Publicado: (1911) -
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis
por: Müller-Jensen, Leonie, et al.
Publicado: (2022) -
Neurotropic Coronavirus Infections
por: Perlman, Stanley, et al.
Publicado: (2016)